Vascular access devices are used for communicating fluid with the anatomy of a patient. For example, vascular access devices, such as catheters, are commonly used for infusing fluid, such as saline solution, various medicaments, and/or total parenteral nutrition, into a patient, withdrawing blood from a patient, and/or monitoring various parameters of the patient's vascular system.
A variety of clinical circumstances, including massive trauma, major surgical procedures, massive burns, and certain disease states, such as pancreatitis and diabetic ketoacidosis, can produce profound circulatory volume depletion. This depletion can be caused either from actual blood loss or from internal fluid imbalance. In these clinical settings, it is frequently necessary to infuse blood and/or other fluid rapidly into a patient to avert serious consequences.
Additionally, the ability to inject large quantities of fluid in a rapid manner may be desirable for certain other medical and diagnostic procedures. For example, some diagnostic imaging procedures utilize contrast media enhancement to improve lesion conspicuity in an effort to increase early diagnostic yield. These procedures necessitate viscous contrast media be injected by a specialized “power injector” pump intravenously at very high flow rates, which establishes a contrast bolus or small plug of contrast media in the bloodstream of the patient which results in enhanced image quality.
Power injection procedures generate high pressures within the infusion system, thereby requiring specialized vascular access devices, extension sets, media transfer sets, pump syringes, and bulk or pre-filled contrast media syringes. As the concentration (and thereby viscosity) and infusion rate of the contrast media are increased, bolus density also increases resulting in better image quality via computed tomography (CT) attenuation. Therefore, a current trend in healthcare is to increase the bolus density of the contrast media by increasing both the concentration of the contrast media and the rate at which the media is infused into the patient, all of which ultimately drives system pressure requirements higher.
Intravenous infusion rates may be defined as either routine, generally up to 999 cubic centimeters per hour (cc/hr), or rapid, generally between about 999 cc/hr and 90,000 cc/hr (1.5 liters per minute) or higher. For some diagnostic procedures utilizing viscous contrast media, an injection rate of about 1 to 10 ml/second is needed to ensure sufficient bolus concentration. Power injections of viscous media at this injection rate produce significant back pressure within the infusion system that commonly results in a failure of the infusion system components.
Traditionally, rapid infusion therapy entails the use of an intravenous catheter attached to a peristaltic pump and a fluid source. A patient is infused as a tip portion of the catheter is inserted into the vasculature of a patient and the pump forces a fluid through the catheter and into the patient's vein. Current rapid infusion therapies utilize a catheter and catheter tip with geometries identical to those used with traditional, routine infusion rates. These geometries include a tapering catheter tip such that the fluid is accelerated as the fluid moves through the catheter tip and exits into a patient's vasculature. This acceleration of the infused fluid is undesirable for several reasons.
For example, the tapered catheter results in a greater backpressure for the remainder of the catheter assembly. This effect is undesirable due to the limitations of the pumping capacity of the infusion pump as well as the limited structural integrity of the components and subcomponents of the infusion system. For example, if the backpressure becomes too great, the pump's efficiency may decrease and certain seals or connections within the infusion system may fail. Additionally, the fluid acceleration in the catheter tip results in a recoil force that may cause the catheter tip to shift within the patient's vein thereby displacing the catheter and/or damaging the patient's vein and/or injection site. Fluid acceleration also increases the jet velocity of the infusant at the tip of the catheter. In some procedures, the fluid jet may pierce the patient's vein wall thereby leading to extravasation or infiltration. Not only is this uncomfortable and painful to the patient, but infiltration may also prevent the patient from receiving the needed therapy.
Accordingly, the problem of increased exit velocity of an infusant during rapid infusion procedures remains to be solved.
The systems and methods of the present disclosure have been developed in response to problems and needs in the art that have not yet been fully resolved by currently available infusion systems and methods. Thus, these systems and methods are developed to provide for safer and more efficient rapid infusion procedures.
One aspect provides an improved vascular access device for use in combination with a vascular infusion system capable of rapidly delivering an infusant to the vascular system of a patient. The vascular access device generally includes an intravenous catheter configured to access the vascular system of a patient. The intravenous catheter is coupled to the vascular infusion system via a section of intravenous tubing. The material of the intravenous catheter may include a polymer or metallic material compatible with infusion procedures.
In some aspects, a tip portion of the intravenous catheter is modified to include a plurality of diffusion holes. The tip portion generally comprises a tapered profile, wherein the outer and inner surface of the tip taper towards the distal end of the catheter. The tapered outer surface provides a smooth transition between the narrow diameter of the catheter tip opening and the larger diameter of the catheter tubing. Thus, as the tip of the catheter is introduced into the vein of a patient, the tapered outer surface facilitates easy insertion of the catheter through the access hole. The tapered inner surface is generally provided to tightly contact the outer surface of an introducer needle housed within the lumen of the catheter. The introducer needle is provided to create an opening into the vein of patient through which the catheter tip is inserted. The tapered inner surface ensures a tight seal between the inner surface of the catheter and the outer surface of the needle. Following placement of the catheter, the introducer needle is removed.
As an infusant passes through the tapered portion of the inner surface, the fluid flow of the infusant is accelerated due to the decreased volume through the tapered tip. Thus, in some embodiments a plurality of diffusion holes are formed through the wall thickness of the intravenous catheter so as to provide a plurality of pathways through the wall of the intravenous catheter. Thus, as infusant flows through the catheter toward the tip of the catheter, a portion of the bulk flow through the catheter is diverted through the diffusion holes rather than through the main opening of the catheter tip. As such, the pressure within the infusion system is reduced as compared to systems incorporating standard intravenous catheter. Additionally, the plurality of diffusion holes reduce the jet velocity issued from the tip of the catheter, thereby enabling increased flow rates as required by some diagnostic procedures without additional damage to the vein wall.
In some aspects, the diffusions holes are arranged on the catheter tip in a staggered array such that an upstream diffusion hole is unaligned with a downstream hole. As such, the fluid flow of an infusant that issues from a downstream diffusion hole is not disturbed by the fluid flow of an infusant that issues from an upstream diffusion hole. This feature provides increased flow efficiency through downstream diffusion holes.
In some aspects, a first set of diffusion holes is disposed in a first annular ring at an upstream, axial position of the catheter tip. A second set of diffusion holes is further disposed in a second annular ring at an axial position of the catheter tip that is downstream from the first annular ring. In some embodiments, the holes of the first annular ring are staggered from the holes of the second annular ring so as to be generally unaligned. In other embodiments, the holes of the first annular ring are axially staggered from the holes of the second annular ring from about 15° to about 60°. Finally, in some embodiments the holes of the first annular ring are axially staggered from the holes of the second annular ring about 45°.
In some aspects, the diffusion holes include an inner wall surface that may be angled relative to the inner surface of the catheter lumen. In some embodiments, the inner surface of a diffusion hole is oriented to an acute angle relative to the inner surface of the catheter lumen. In other embodiments, an inner surface of the diffusion hole is oriented to an angle from about 15° to about 75° relative to the inner surface of the catheter lumen. In some embodiments, the bore angle of the diffusion hole is selected so as to optimize flow efficiency through the diffusion hole, catheter tension within the vein, centralized positioning of the catheter tip within the vein, and reduction of system pressure and tip jet velocity within an infusion system.
In some aspects, one or more diffusion holes are positioned on the distal end of a catheter body member. Specifically, the diffusion holes include a flow breaking feature. For example, in some embodiments, the flow breaking feature comprises the association of two or more diffusion holes, wherein the axis of each hole is oriented to cross the axis of another hole in the space exterior to the catheter body. As such, the fluid jet streams exiting these holes will collide and disrupt the jet streams. The resulting, scattered jet stream loses energy and momentum more quickly than a singular jet stream, thus decreasing stress and impact on vessel walls.
In some aspects, the flow breaking feature of the diffusion holes includes a flow disrupter. Specifically, in some embodiments, the flow disrupter includes a wedged extension on the hole. In other embodiments, the flow disrupter includes an inward projection. For example, in some embodiments, the inward projection is disposed on the inner wall surface of the hole. In some embodiments, the hole has a substantially tear-drop shape. In some embodiments, the hole has an elongated geometry. The flow disrupter will disrupt the jet stream flowing through the diffusion hole either by breaking it up, or by flattening its shape. Accordingly, a stream exiting the diffusion hole will have a thinner cross section or a disrupted and scattered flow. The resulting, disrupted jet stream loses energy and momentum more quickly than a singular jet stream, thus decreasing stress and impact on vessel walls.
In some aspects, a catheter has a catheter body with a lumen and a distal lumen opening. The catheter's lumen extends through the catheter body along a longitudinal axis of the catheter body. A hole is formed through a wall of a distal portion of the catheter body. A portion of the proximal surface of the hole is inclined at an acute angle with respect to the longitudinal axis of the catheter body. The acute angle of the proximal hole surface opens proximally with respect to the catheter body.
The present invention further includes methods for manufacturing an intravenous catheter for diffusing an infusant. Some methods include the steps of providing an intravenous catheter and forming a plurality of staggered holes through the wall thickness of the intravenous catheter. Some methods of the present invention further include using a laser drill to provide the various staggered holes.
In order that the manner in which the above-recited and other features and advantages of the invention are obtained will be readily understood, a more particular description of the invention briefly described above will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. These drawings depict only typical embodiments of the invention and are not therefore to be considered to limit the scope of the invention.
Embodiments of the present invention will be best understood by reference to the drawings, wherein like reference numbers indicate identical or functionally similar elements. It will be readily understood that the components of the present invention, as generally described and illustrated in the figures herein, could be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description, as represented in the figures, is not intended to limit the scope of the invention as claimed, but is merely representative of presently preferred embodiments of the invention.
The systems and methods of the present invention are generally designed for use in combination with a vascular infusion system capable of rapidly delivering an infusant to the vascular system of a patient. Referring now to
An injector pump 120 generally comprises a fluid pumping apparatus configured to rapidly deliver an infusant, such as blood, medicaments, and CT scan contrast agents to a patient's vascular system. Desirable infusants may also include various fluids often of high viscosity as required for medical and diagnostic procedures. In some embodiments, the injector pump 120 comprises a power injector capable of delivering an infusant to a patient at flow rates from about 10 mL/hour up to about 1200 mL/minute. In some embodiments, a high infusion flow rate is desirable for medical procedures which require enhanced bolus density of an infusant in a patient's vascular system. For example, a trend in diagnostic imaging procedures is to utilize contrast media enhancement, which requires more viscous contrast media to be pushed into a patient at a higher flow rate, thereby resulting in increased image quality. Thus, in some embodiments an injector pump 120 and a vascular access device 112 are selected to compatibly achieve a desired infusion flow rate.
A coiled extension set 130 generally comprises flexible or semi-flexible polymer tubing configured to deliver an infusant from the injector pump 120 to the vascular access device 112. The extension set 130 includes a first coupler 132 for connecting the extension set 130 to a downstream device 112 or 140. The extension set 130 also includes a second coupler 134 for connecting the extension set 130 to the injector pump 120. A coiled configuration of the extension set 130 generally prevents undesirable kinking or occlusion of the set 130 during infusion procedures. However, one of skill in the art will appreciate that the extension set 130 may include any configuration capable of efficiently delivering an infusant from an injector pump 120 to the patient via a vascular access device 112. In some embodiments, the extension set 130 is coupled between a syringe and a vascular access device whereby an infusant is manually injected into a patient. In other embodiments, the infusion system comprises only a syringe and a vascular access device, in accordance with the present invention.
The vascular access device 112 generally comprises a peripheral intravenous catheter 114. A peripheral intravenous catheter 114 in accordance with the present invention generally comprises a short or truncated catheter (usually 13 mm to 52 mm) that is inserted into a small peripheral vein. Such catheters generally comprise a diameter of approximately a 14 gauge catheter or smaller (on a Stubs scale). Peripheral intravenous catheters 114 are typically designed for temporary placement. The short length of the catheter 114 facilitates convenient placement of the catheter but makes them prone to premature dislodging from the vein due to movement of the patient and/or recoil forces experienced during infusion procedures. Furthermore, unlike midline or central peripheral catheters, peripheral intravenous catheters 114 in accordance with the present invention comprise a tapered catheter tip 146 to accommodate use with an introducer needle (not shown) designed to aid in insertion of the catheter 114.
An introducer needle is typically inserted through the catheter 114 such that a tip of the needle extends beyond the tapered tip 146. The tapered geometry of the tapered tip 146 conforms tightly to the outer surface of the introducer needle. Both the outer surface and the inner surface of the tip 146 are tapered towards the distal end of the catheter 114. The outer surface of the tip 146 is tapered to provide a smooth transition from the smaller profile of the introducer needle to the larger profile of the catheter outer diameter. Insertion of the introducer needle into the vein of the patient provides an opening into the vein through which the tapered tip 146 of the catheter 114 is inserted. The tapered outer surface of the tip 146 enables easy insertion of the catheter 114 into the opening. Once the peripheral intravenous catheter 114 is inserted into the vein of the patient, the introducer needle (not shown) is removed from the lumen of the catheter 114 to permit infusion via the catheter 114.
The tapered inner surface of the tip 146 provides a secure seal between the inner surface of the catheter tip 146 and the outer surface of the introducer needle (not shown). Additionally, the tapered inner surface of the tip 146 causes an acceleration of infusant within the lumen of the catheter as the infusant nears and flows through the catheter tip 146. Specifics regarding the geometries of the tapered inner surface of the tip 146 are provided in connection with
A desired infusant is typically delivered to the catheter 114 via a section of intravenous tubing 116 coupled to the catheter 114. In some embodiments, a y-adapter 118 is coupled to an end of the tubing 116 opposite the catheter 114, enabling the vascular access device 112 to be coupled to the remainder of the vascular infusion system 100. One of skill in the art will appreciate the possible variations and specific features of available vascular access devices 112, as are commonly used in the medical and research professions. For example, in some embodiments a catheter 114 in accordance with the present invention may include additional access sites, clamps, parallel intravenous lines, valves, couplers, introducer needles, coatings, and/or materials as desired to fit a specific application.
Referring now to
The catheter adapter 218 facilitates delivery of an infusant within the intravenous tubing 216 to a patient via the tubular body member 220. An inner lumen of the catheter adapter 218 is in fluid communication with both an inner lumen of the intravenous tubing 216 and an inner lumen of the tubular body member 220. In some embodiments, catheter adapter 218 further comprises an access port 222. The access port 222 is generally provided to permit direct access to the inner lumen of the catheter adapter 218. In some embodiments, the access port 222 is accessed via a needle and a syringe to deliver an infusant to a patient via the tubular body member 220. In other embodiments, an introducer needle or guide wire is inserted into the access port 222 and advanced through the inner lumen of the tubular body member 220. In some embodiments, a tip portion of the introducer needle or guide wire (not shown) extends beyond a tip portion 240 of the tubular body member 220. As such, the tip portion of the introducer needle or guide wire may provide an opening into the vascular system of a patient into which the tubular body member 220 is inserted. Following placement of the tubular body member 220 into the vein of the patient, the introducer needle or guide wire is removed from the access port 222 thereby establishing fluid communication between the tubular body member 220, the catheter adapter 218 and the intravenous tubing 216.
In some embodiments, the tubular body member 220 comprises an intravenous catheter. The intravenous catheter 220 generally comprises a flexible or semi-flexible biocompatible material, as commonly used in the art. In some embodiments, the intravenous catheter 220 comprises a polymer material, such as polypropylene, polystyrene, polyvinylchloride, polytetrafluoroethylene, and the like. In other embodiments, the intravenous catheter 220 comprises a metallic material, such as surgical steel, titanium, cobalt steel, and the like.
The tubular body member 220 may comprise any length, where the length is selected based on the intended application of the catheter 214. For some applications, the tubular body member 220 is inserted into a peripheral vein of the patient. In other applications, the tubular body member 220 is inserted into a central vein of the patient. For rapid infusion applications, the tip portion 240 of the tubular body member 220 is modified to include a plurality of diffusion holes 250. The diffusion holes 250 are generally provided to divert fluid from the main channel of flow through the inner lumen of the tubular body member 220. As such, the diffusion holes 250 effectually slow the jet of infusant which issues from the catheter tip 240 during rapid infusion procedures. Additionally, the plurality of diffusion holes 250 increase the accumulative area of the catheter tip opening 242 to relieve the overall pressure in the vascular infusion system 100.
Referring now to
Referring now to
Computational fluid dynamic analysis of the 90° side holes 350 reveals that only a first half 374 of each hole 350 cross section is utilized by the fluid flow 390. In some embodiments, a second half 376 of the 90° side holes 350 cross section comprises a recirculation eddy 392. Therefore, in some embodiments the 90° side hole 350 configuration may demonstrate approximately fifty percent flow efficiency through each side hole 350.
Referring now to
In some embodiments, a selected array of the diffusion holes 450 increases the distance between adjacent holes 450 thereby structurally strengthening the tip 440 of the intravenous catheter 414, as compared to some linear hole arrays. In other embodiments, a selected array of the diffusion holes 450 further streamlines infusant issued from the diffusion holes 450 thereby reducing the energy necessary to divert bulk flow from the main stream of the catheter lumen 490 into the diffusion holes 450.
For example, in some embodiments of the present invention the diffusion holes 450 have been arranged in a staggered configuration, as shown. Accordingly, an upstream hole 456 is unaligned with an adjacent, downstream hole 458. Furthermore, downstream hole 458 is unaligned with an adjacent, downstream hole 460. In some embodiments, upstream hole 456 is directly aligned with downstream hole 460 along a common axis 480. In other embodiments, upstream hole 456, downstream hole 458 and downstream hole 460 are each unaligned with each other, such that none of the holes are aligned along a common axis. In some embodiments, an upstream hole 456 is axially staggered from a downstream hole 458 from about 15° to about 60°. Finally, in some embodiments, an upstream hole 456 is axially staggered from a downstream hole 458 approximately 45°.
The diffusion holes 450 are annularly organized on the tapered portion of the tip 440 of the intravenous catheter 414 in a staggered configuration, as previously discussed. A first annular ring 402 comprises a plurality of diffusion holes 450 forming a first upstream ring of diffusion holes. In some embodiments, the holes of the first annular ring 402 are axially spaced an equal distance from adjacent holes of the first annular ring 402. In other embodiments, a non-uniform axially spacing is applied to the holes of the first annular ring 402. In some embodiments, a second annular ring 404 is provided downstream from the first annular ring 402, the diffusion holes of the second annular ring 404 being staggeredly positioned relative to the diffusion holes of the first annular ring 402. Finally, in some embodiments a third annular ring 406 is provided downstream from the second annular ring 404, the diffusion holes of the third annular ring 406 being staggeredly positioned relative to the diffusion holes of the second annular ring 404.
A gap 424 is provided between adjacent holes of the first annular ring 402. In some embodiments, the gap 424 is provided to accommodate the width of downstream hole 458, such that the downstream hole 458 and the gap 424 are aligned along a common axis (not shown). Furthermore, a downstream gap 428 is provided to accommodate the width of an upstream hole 466, such that the upstream hole 466 and the downstream gap 428 are aligned along a common axis (not shown). The axial alignment of the upstream gap 424 and the downstream hole 458 prevents wake effect due to the absence of a diffusion hole directly upstream from the downstream hole 458. Similarly, the axial alignment of the downstream gap 428 and the upstream hole 466 prevents wake effect due to the absence of a diffusion hole directly downstream from the upstream hole 466.
The staggered configuration of the first, second and third annular rings 402, 404 and 406 provides an elongate gap 426 forming a space between an upstream diffusion hole 452 of the first annular ring and an axially aligned downstream diffusion hole 454 of the third annular ring 406. The length of the elongate gap 426 generally provides sufficient distance between an upstream diffusion hole 452 and a downstream diffusion hole 454, so that the fluid pressure of an infusant from the upstream hole 452 is approximately equal to the fluid pressure of an infusant from the downstream hole 454. Thus, the staggered configuration of the diffusion holes 450 ensures equal flow efficiency from upstream and downstream diffusion holes 452 and 454.
In some embodiments, the diffusion holes 450 are formed through the catheter wall 474 such that an inner surface 464 of each hole 450 is oriented at an angle 470 that is acute to an inner, tapered surface 482 of the catheter lumen 490, as shown in
As hereinbefore set forth, diffusion holes and diffusion hole arrays diminish the exit force of fluid issuing from a catheter tip. Attention will now be drawn to the geometry of the diffusion holes (also referred to herein simply as “holes”), and specifically to geometries which further diminish the exit force of fluid issuing from a catheter tip.
In addition to employing non-circular hole geometries, flow disruption may also be facilitated by including additional flow breaking feature on the diffusion hole. A “flow breaking feature” refers to a feature of the hole that substantially breaks up, thins, or slows a jet of fluid exiting a hole so that the jet will lose speed more quickly within the vein. Flow breaking features are hole features that facilitate the break up the flow of a fluid jet as it passes through and/or exits the hole. Flow breaking features include a flow disrupter, elongated hole geometries, and hole orientations such that the axis of flow of two or more holes collides. Non-limiting examples of a hole breaking features including two or more holes whose axis of flow collide are illustrated in
As indicated, one type of flow breaking features is a flow disrupter. A “flow disrupter” refers to a deviation in a hole's geometry from a rounded hole, a circular hole, or an elliptical hole. Thus, flow disrupters include inward projections and pointed extensions. A non-limiting example of a hole having a flow disrupter is a substantially tear-shaped hole including a pointed extension. Another non-limiting example of a hole having a flow disrupter is a hole having one or more inward projection. An “inward projection” refers to a portion of a hole's periphery which projects toward the inner portion of the hole. In this way, there exists a cross sectional area of the hole in which a straight line interposed over the cross section could cross the perimeter of the hole more than two times, as illustrated in
Referring now to
Referring now to
Fluid passing through the catheter 508 travels generally down the lumen toward the catheter lumen opening 504. The inner surface of the lumen includes one or more inner hole openings 530, through which some fluid enters. As fluid travels through the hole, structures and geometries of the inner wall surface 520 of the hole modify the jet of fluid that exits through the outer hole opening 532. Additionally, the shapes of the inner and outer hole openings 530 and 532 affect the exiting jet of fluid. In some embodiments, the shape of the inner hole opening differs from the shape of the outer hole opening to modify the exiting fluid stream with enhanced dissipation properties.
With continued reference to
Referring now to
Referring now to
In some embodiments, as in
Referring now to
Referring now to
To achieve effective collisions, the location of collision may be closer to the catheter surface than the distance between the location of the holes on the catheter body 702 and a vein wall so that the impact actually occurs rather than the two jets impacting the vein wall. Accordingly, in some embodiments, the location of collision is configured to be a distance away from the outer surface of the catheter, wherein the distance is less than the overall thickness of the catheter body 702. In other embodiments, the distance is less than 150% the thickness of the catheter body 702. In other embodiments, the distance is less than 200% the thickness of the catheter body 702. In yet other embodiments, the distance is less than 300% the thickness of the catheter body 702. Still, in other embodiments, the distance is less than 50% the thickness of the catheter body 702. Furthermore, in some embodiments, the angle 718 between the first hole axis 708 and the second hole axis 710 is between ninety 15-90 degrees.
In some embodiments, flow can be broken by the collision of flow exiting a first diffuser hole and flow exiting a second, smaller diffuser hole. For example, one or more small diffuser holes is included on the catheter tip, and oriented so that fluid exiting therefrom collides with fluid exiting a larger diffuser hole. This way a greater number of holes can be included in the catheter tip without substantially weakening the tip with numerous holes of the same size.
Additionally, in some embodiments, fluid exiting a diffuser hole collides with fluid exiting two or more other diffuser holes. Referring now to
In some embodiments, a single diffuser hole includes more than one flow breaking features. Examples of jet breaking features are described herein, including at least inward projections, wedged extensions, an elongated hole geometry, and hole axis orientations that result in collisions with other fluid jets. For example, in some embodiments, a hole includes an inward projection and has an axis orientation that collides with that of another hole. In addition, in some embodiments, the hole further includes a wedged extension. In other embodiments, other combinations of flow breaking features are combined to provide a less harmful, more effective catheter diffuser hole and diffuser hole array configuration.
From the foregoing, it will be seen that one or more flow breaking features can be included on one or more catheter diffuser holes on a catheter tip. The flow breaking feature can substantially breaks up, thins, or slows a jet of fluid exiting a hole so that the jet will lose speed more quickly within the vein and cause less damage to vessel walls. In particular, flow breaking features are particularly advantageous when used in rapid infusion therapy that uses highly infusant velocities to rapidly introduce a bolus of fluid into a patient through the catheter tip. During these procedures, one or more flow breaking features of a diffuser hole can increase infusion patient comfort, decrease patient pain, allow for greater infusion velocities, and prevent vessel damage.
Reference will now be made to
As previously discussed, in some embodiments, a hole with a trailing hole surface that is inclined forward relative to the skin and tissue during catheter insertion, such as the hole 552 of
Referring specifically to
In some embodiments, the side hole 812 is disposed on the tapered portion 808 of the catheter body 802 to at least partially reduce the adverse effects of the tapered portion 808 of a vascular infusion system, while preserving the tapered portion's beneficial functions. As mentioned, a tapered portion 808 can provide a smooth transition between the narrow diameter of the catheter tip opening and the larger diameter of the catheter body 802. However, the tapered portion 808 can also negatively affect the vascular infusion system by accelerating fluid therethrough which can cause back pressure within the system, recoil force, broken system seals, and an increased risk of extravasation due to the increased exit velocity. Accordingly, by disposing the side hole 812 on the tapered portion 808 fluid flows through the hole 812, thus minimizing increases in acceleration with its attendant effects. However, in other embodiments, one or more holes 812 are disposed either partially or entirely on a non-tapered portion of the catheter body 802, which can also serve to reduce fluid volume through the catheter and thus decrease back pressure within the system, recoil force, broken system seals, and an increased risk of extravasation.
The hole trailing surface 814 can have a variety of shapes, angles, and configurations, as shown in
Reference will now be made to
As further shown in
As mentioned above, two or more holes 812 of a catheter body 802 can have a proximally-inclined proximal surface 814. For instance,
In some configurations, a hole 812, such as those illustrated in
In some configurations, the proximal surface 814 of the hole 812 is curved, resulting in a substantially funnel shaped hole portion that has no defined corners that may retain fluid and/or be susceptible to bio-film growth. For instance,
Additionally or alternatively, in some embodiments, the proximal surface 814 is rounded. For example,
In some instances, the catheter hole 812 can combine an inward projection, as previously mentioned, with a proximally-inclined proximal surface 814 or proximally-inclined portion of a proximal surface 814 to receive at least part of the benefit of each feature. For example,
Many of the holes and hole features described herein involve more than simple cylindrical holes. Accordingly, manufacturing these holes and hole features may require more than a simple drilling process. Rather, in some instances, these holes are manufactures using a laser ablation process, a hot forming process, or a re-flow process. Furthermore, these holes or hole features can be formed during the catheter tipping process. Additionally, a combination of these processes can be used to form the holes.
From the foregoing it will be seen that some holes can include proximally included proximal surfaces that lessen the force required to insert a catheter into a patient by substantially preventing tissue snagging and shearing that might otherwise be caused by non-proximally inclined proximal surfaces. This feature benefits patients and medical personnel by facilitating the catheter insertion procedure and decreasing the likelihood of resulting tissue damage.
To decrease the amount of contrast media required for a diagnosis, the concentration of contrast media per unit volume of blood needs to be increased by increasing the volumetric flow rate of the of contrast media without increasing the catheter tip velocity. The elements of the present invention achieve these required objectives, as demonstrated in the examples below.
The jet velocities at the tip of a standard catheter are in excess of 1,000 in/sec for a 5 ml/sec volumetric flow rate setting, which results in a large force applied to the vein wall of a patient. This force is treacherous for patients with non-optimal vein structure provisions increasing the likelihood of extravasation or intima damage with increasing flow rates.
Jet tip velocities of a standard 22 GA×1.00″ catheter (V_tip Current) were compared to a 22 GA×1.00″ catheter (V_tip Ex. 1—V_tip Ex. 4) modified to include a plurality of diffusion holes, as described in connection with
Internal pressures within an infusion system were compared between an infusion system using a standard 22 GA×1.00″ catheter and an infusion system using a 22 GA×1.00″ catheter (P_inj #1 and P_inj #2) modified to include a plurality of diffusion holes, as described in connection with
System pressure was measured both within each infusion pump (P_inj Current, P_inj 1 and P_inj 2) and the inner lumen of each catheter (P_sept Current, P_sept 1 and P_sept 2). System pressure was tested and recorded at flow rates of 1 ml/sec, 2 ml/sec, 3 ml/sec, 4 ml/sec, and 5 ml/sec. System pressures at each flow rate where then graphed, as shown in
The results of the experiment demonstrate an increase in the volumetric flow rate by decreasing system pressure by nearly 30%, with the greatest reduction in pressure being shown within the lumen of the modified catheters.
Computation fluid dynamic analysis was conducted on a standard 22 GA×1.00″ catheter modified to include a plurality of diffusion holes bored approximately 45° relative to the inner wall surface of the catheter. The analysis revealed an addition 6% diversion of bulk flow from the main stream into the diffusion holes, as compared to a standard 22 GA×1.00″ catheter having a plurality of diffusion holes bored 90° relative to the inner wall surface of the catheter. The analysis further revealed a significant increase in fluid flow 492 through the cross section of the diffusion hole 450, as compared to the straight holes of the standard catheter. While the diffusion holes 450 of the present invention did show a slight recirculation eddy 494, the recirculation eddy 494 was significantly weaker as compared to the circulation eddy 392 of the standard catheter. A representative rendering of the fluid flow 492 is shown in
In standard peripheral intravenous catheters, the inner lumen of the catheter tapers towards the tip of the catheter resulting in a recoil force as an infusant accelerates through the constriction. This force is akin to the force felt when holding a fire hose. Like a fire hose, a catheter tip under the compressive recoil force is unstable and can oscillate violently within the vein (also known as catheter whip) causing vein damage, as previously discussed. If enough infusant is turned from the axial direction through diffusion holes, then the recoil force will become negative and actually pull the catheter tip into tension; the tensioned state of the catheter tip providing great stability to the inserted catheter. Therefore, in some embodiments the bore angle is strategically selected to balance between increased flow through the diffusion holes and decreased recoil force on the catheter tip by reducing the axial direction of infusant flowing through the diffusion holes.
The bore angle further affects the positioning of the catheter within the vein. For example, when inserted in to a vein the venous catheter generally extends through the skin and into the vein at approximately 30°. As such, the tip of the venous catheter commonly contacts or rests against the inner wall of the vein opposite the insertion site of the catheter. As fluid flow increases, high jet velocity from the catheter tip is exerted directly on the inner wall of the vein. However, when the tip of the venous catheter is modified to include diffusion ports, the diverted infusant that issues from the diffusion ports pushes the catheter tip away from the vein wall resulting in a centralized position of the catheter tip within the vein. Thus, the jet velocity from the tip is directed into the fluid stream of the vein rather than into the vein wall.
The present invention may be embodied in other specific forms without departing from its structures, methods, or other essential characteristics as broadly described herein and claimed hereinafter. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application is a continuation of U.S. Pat. No. 9,399,112, issued on Jul. 26, 2016, entitled A CATHETER HOLE HAVING AN INCLINED TRAILING EDGE which claims the benefit of U.S. Provisional Application No. 61/364,470, filed Jul. 15, 2010, entitled SIDE HOLE PROFILING IN DIFFUSION TIPPED CATHETER TO REDUCE INSERTION DRAG AND INCREASE PATIENT COMFORT and which is also a continuation-in-part of U.S. Pat. No. 8,496,629, issued on Jul. 30, 2013, entitled A CATHETER HOLE HAVING A FLOW BREAKING FEATURE which is a continuation-in-part of U.S. Pat. No. 8,403,911, issued on Mar. 26, 2013, entitled SYSTEMS AND METHODS FOR IMPROVING CATHETER HOLE ARRAY EFFICIENCY which claims the benefit of U.S. Provisional Application No. 61/046,843, filed Apr. 22, 2008 entitled POWER PIVC HOLE ARRAY EFFICIENCY IMPROVEMENTS, each of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1879249 | Honsaker | Sep 1932 | A |
2972779 | Cowley | Feb 1961 | A |
3670729 | Bennett | Jun 1972 | A |
3713442 | Walter | Jan 1973 | A |
3828767 | Spiroff | Aug 1974 | A |
4173981 | Mortensen | Nov 1979 | A |
4292270 | Hannah et al. | Sep 1981 | A |
4330497 | Agdanowski | May 1982 | A |
4563180 | Jervis et al. | Jan 1986 | A |
4583968 | Mahurkar | Apr 1986 | A |
4639246 | Dudley | Jan 1987 | A |
4639252 | Kelly et al. | Jan 1987 | A |
4657024 | Coneys | Apr 1987 | A |
4661094 | Simpson | Apr 1987 | A |
4717379 | Ekholmer | Jan 1988 | A |
4717381 | Papantonakos | Jan 1988 | A |
4754752 | Ginsburg | Jul 1988 | A |
4770652 | Mahurkar | Sep 1988 | A |
4784638 | Ghajar et al. | Nov 1988 | A |
4863441 | Lindsay et al. | Sep 1989 | A |
4894057 | Howes | Jan 1990 | A |
4895561 | Mahurkar | Jan 1990 | A |
4950232 | Ruzicka et al. | Aug 1990 | A |
4961731 | Bodicky et al. | Oct 1990 | A |
4968307 | Dake et al. | Nov 1990 | A |
5037403 | Garcia | Aug 1991 | A |
5085635 | Cragg | Feb 1992 | A |
5088991 | Weldon | Feb 1992 | A |
5135599 | Martin et al. | Aug 1992 | A |
5180364 | Ginsburg | Jan 1993 | A |
5201723 | Quinn | Apr 1993 | A |
5221256 | Mahurkar | Jun 1993 | A |
5221257 | Rosenbloom | Jun 1993 | A |
5234406 | Drasner et al. | Aug 1993 | A |
5250034 | Appling et al. | Oct 1993 | A |
5267979 | Appling et al. | Dec 1993 | A |
5334154 | Samson et al. | Aug 1994 | A |
5352205 | Dales et al. | Oct 1994 | A |
5364344 | Beattie et al. | Nov 1994 | A |
5374245 | Mahurkar | Dec 1994 | A |
5380307 | Chee et al. | Jan 1995 | A |
5451216 | Quinn | Sep 1995 | A |
5507751 | Goode et al. | Apr 1996 | A |
5507995 | Schweich, Jr. et al. | Apr 1996 | A |
5536261 | Stevens | Jul 1996 | A |
5542925 | Orth | Aug 1996 | A |
5571093 | Cruz et al. | Nov 1996 | A |
5578006 | Schon | Nov 1996 | A |
5591129 | Shoup | Jan 1997 | A |
5616137 | Lindsay | Apr 1997 | A |
5643226 | Cosgrove | Jul 1997 | A |
5643228 | Schucart et al. | Jul 1997 | A |
5647846 | Berg et al. | Jul 1997 | A |
5662619 | Zarate | Sep 1997 | A |
5725495 | Strukel et al. | Mar 1998 | A |
5782811 | Samson et al. | Jul 1998 | A |
5830181 | Thornton | Nov 1998 | A |
5843017 | Yoon | Dec 1998 | A |
5857464 | Desai | Jan 1999 | A |
5876383 | Grooters et al. | Mar 1999 | A |
5899890 | Chiang et al. | May 1999 | A |
5976114 | Jonkman et al. | Nov 1999 | A |
6052612 | Desai | Apr 2000 | A |
6102903 | Tremulis | Aug 2000 | A |
6129700 | Fitz | Oct 2000 | A |
6132405 | Nilsson et al. | Oct 2000 | A |
6193685 | Goodin | Feb 2001 | B1 |
6197014 | Samson et al. | Mar 2001 | B1 |
6221049 | Selmon et al. | Apr 2001 | B1 |
6280423 | Davey et al. | Aug 2001 | B1 |
6293958 | Berry et al. | Sep 2001 | B1 |
6514236 | Stratienko | Feb 2003 | B1 |
6533763 | Schneiter | Mar 2003 | B1 |
6540714 | Quinn | Apr 2003 | B1 |
6547769 | VanTassel et al. | Apr 2003 | B2 |
6641564 | Kraus | Nov 2003 | B1 |
6659134 | Navis | Dec 2003 | B2 |
6669679 | Savage et al. | Dec 2003 | B1 |
6702776 | Quinn | Mar 2004 | B2 |
6758836 | Zawacki | Jul 2004 | B2 |
6758857 | Cioanta et al. | Jul 2004 | B2 |
6857464 | LeBlanc et al. | Feb 2005 | B2 |
6858019 | McGuckin, Jr. et al. | Feb 2005 | B2 |
6866655 | Hackett | Mar 2005 | B2 |
6986752 | McGuckin, Jr. et al. | Jan 2006 | B2 |
7077829 | McGuckin, Jr. et al. | Jul 2006 | B2 |
7108674 | Quinn | Sep 2006 | B2 |
7223254 | Hjalmarsson | May 2007 | B2 |
7686800 | Savage et al. | Mar 2010 | B2 |
7799014 | McGuckin, Jr. et al. | Sep 2010 | B2 |
8066660 | Gregersen et al. | Nov 2011 | B2 |
8152951 | Zawacki et al. | Apr 2012 | B2 |
8292841 | Gregersen | Oct 2012 | B2 |
8323227 | Hamatake et al. | Dec 2012 | B2 |
8403911 | Adams et al. | Mar 2013 | B2 |
8496629 | McKinnon et al. | Jul 2013 | B2 |
8684967 | Engel et al. | Apr 2014 | B2 |
8747343 | MacMeans et al. | Jun 2014 | B2 |
8876752 | Hayakawa | Nov 2014 | B2 |
9044576 | Onuma | Jun 2015 | B2 |
9364634 | Adams et al. | Jun 2016 | B2 |
9399112 | Shevgoor et al. | Jul 2016 | B2 |
9402975 | Shevgoor | Aug 2016 | B2 |
9789282 | McKinnon et al. | Oct 2017 | B2 |
20020072712 | Nool et al. | Jun 2002 | A1 |
20030023200 | Barbut et al. | Jan 2003 | A1 |
20030093027 | McGuckin, Jr. et al. | May 2003 | A1 |
20030093029 | McGuckin, Jr. et al. | May 2003 | A1 |
20040030319 | Korkor et al. | Feb 2004 | A1 |
20040158211 | Rogers et al. | Aug 2004 | A1 |
20040159360 | Navis | Aug 2004 | A1 |
20040193102 | Haggstrom | Sep 2004 | A1 |
20050119597 | O'Mahony et al. | Jun 2005 | A1 |
20050124969 | Fitzgerald et al. | Jun 2005 | A1 |
20050192560 | Walls et al. | Sep 2005 | A1 |
20050197633 | Schwartz et al. | Sep 2005 | A1 |
20050273076 | Beasley et al. | Dec 2005 | A1 |
20060004316 | Difiore et al. | Jan 2006 | A1 |
20060004325 | Hamatake et al. | Jan 2006 | A1 |
20060027063 | Currier et al. | Feb 2006 | A1 |
20060184048 | Saadat | Aug 2006 | A1 |
20060189959 | Schneiter | Aug 2006 | A1 |
20070073271 | Brucker et al. | Mar 2007 | A1 |
20070100298 | Appling | May 2007 | A1 |
20070100299 | Magnusson | May 2007 | A1 |
20070129690 | Rosenblatt et al. | Jun 2007 | A1 |
20070191810 | Kennedy | Aug 2007 | A1 |
20070197856 | Gellman et al. | Aug 2007 | A1 |
20070255230 | Gross et al. | Nov 2007 | A1 |
20070276354 | Osborne | Nov 2007 | A1 |
20080183128 | Morriss et al. | Jul 2008 | A1 |
20080200791 | Simpson et al. | Aug 2008 | A1 |
20080294096 | Uber, III et al. | Nov 2008 | A1 |
20090076435 | Melsheimer et al. | Mar 2009 | A1 |
20090118661 | Moehle et al. | May 2009 | A1 |
20090187141 | Lareau | Jul 2009 | A1 |
20090287186 | Adams et al. | Nov 2009 | A1 |
20090287189 | Suwito | Nov 2009 | A1 |
20100152698 | Koehler | Jun 2010 | A1 |
20100217234 | Grovener et al. | Aug 2010 | A1 |
20100286657 | Heck | Nov 2010 | A1 |
20110130745 | Shevgoor et al. | Jun 2011 | A1 |
20120022502 | Adams et al. | Jan 2012 | A1 |
20120245562 | Bihlmaier | Sep 2012 | A1 |
Number | Date | Country |
---|---|---|
1323537 | Oct 1993 | CA |
10 2006 052 612 | Feb 2008 | DE |
10 2006 056 049 | May 2008 | DE |
0 299 622 | Jan 1989 | EP |
0 947 211 | Oct 1999 | EP |
1905476 | Apr 2008 | EP |
2 788 223 | Jul 2000 | FR |
S63-71049 | May 1988 | JP |
S64-29271 | Jan 1989 | JP |
H03-501337 | Mar 1991 | JP |
H04-221571 | Aug 1992 | JP |
H10-509071 | Sep 1998 | JP |
H10-323386 | Dec 1998 | JP |
H11-276594 | Oct 1999 | JP |
H11-513293 | Nov 1999 | JP |
H11-332990 | Dec 1999 | JP |
2000-506051 | May 2000 | JP |
2001-170182 | Jun 2001 | JP |
2002-519095 | Jul 2002 | JP |
2002-534222 | Oct 2002 | JP |
2003-520080 | Jul 2003 | JP |
2011-004977 | Jan 2011 | JP |
2011-502583 | Jan 2011 | JP |
2014-525319 | Sep 2014 | JP |
9323105 | Nov 1993 | WO |
9415661 | Jul 1994 | WO |
9937341 | Jul 1999 | WO |
0151116 | Jul 2001 | WO |
0191830 | Dec 2001 | WO |
0193935 | Dec 2001 | WO |
2007081842 | Jul 2007 | WO |
2009052506 | Apr 2009 | WO |
2009132065 | Oct 2009 | WO |
2010070542 | Jun 2010 | WO |
Entry |
---|
“AJR: Modified Catheter Can Reduce Contrast Material Injuries,” HealthImaging.com, Clinical Studies, last updated Sep. 22, 2009, Retrieved from Internet URL: http://www.healthimaging.com/index.php?view=article&id=I8807%3Aajr-modified-cath . . . , on Oct. 21, 2009, p. 1. |
Weber, P.W., et al., “Modifying Peripheral IV Catheters With Side Holes and Side Slits Results in Favorable Changes in Fluid Dynamic Properties During the Injection of Iodinated Contrast Material,” AJR:193, Oct. 2009, vol. 193, No. 4, pp. 970-977. |
Number | Date | Country | |
---|---|---|---|
20160325072 A1 | Nov 2016 | US |
Number | Date | Country | |
---|---|---|---|
61364470 | Jul 2010 | US | |
61046843 | Apr 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13022501 | Feb 2011 | US |
Child | 15216301 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12853804 | Aug 2010 | US |
Child | 13022501 | US | |
Parent | 12427633 | Apr 2009 | US |
Child | 12853804 | US |